Covaxin Demonstrates 77.8 Per Cent Efficacy In Phase 3 Trials: Report
Indian Drug Regulator DCGI Approves Covid-19 Vaccines of AstraZeneca And Bharat Biotech
One Each For Import And Export: How Over-Dependence On China And US Markets Blocks Indian Pharma’s Growth
